Statements on this website may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on the company management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results and/or financial conditions. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to the results of research and development activities; risks related to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; dependence on third party suppliers; key personnel changes; substantial additional funding needs; government regulations; patent and intellectual property matters; competition and changing market landscape; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.